ETJ
Price
$7.88Alerts
Change
+$0.13 (+1.68%)
Updated
Nov 11, 04:52 PM (EDT)
Net Assets
603.7M
Intraday BUY SELL Signals
NVDA
Price
$173.73Alerts
Change
+$4.93 (+2.92%)
Updated
Nov 11 closing price
Capitalization
4.51T
6 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ETJ vs NVDA

ETJ vs NVDA Comparison Chart in %
View a ticker or compare two or three
VS
ETJ vs. NVDA commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETJ is a Buy and NVDA is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ETJ with price predictions
Nov 10, 2026

ETJ sees its Stochastic Oscillator ascending out of oversold territory

On November 04, 2026, the Stochastic Oscillator for ETJ moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 58 instances where the indicator left the oversold zone. In 49 of the 58 cases the stock moved higher in the following days. This puts the odds of a move higher at over 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ETJ's RSI Indicator exited the oversold zone, 26 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

Following a +3.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where ETJ advanced for three days, in 206 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

ETJ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ETJ as a result. In 78 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.

The Moving Average Convergence Divergence Histogram (MACD) for ETJ turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 36 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.

The 50-day moving average for ETJ moved below the 200-day moving average on October 19, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ETJ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

The Aroon Indicator for ETJ entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
a Summary for NVDA with price predictions
Nov 10, 2026

NVDA's RSI Indicator stays in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where NVDA advanced for three days, in 295 of 355 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

NVDA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NVDA as a result. In 55 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 67%.

The Moving Average Convergence Divergence Histogram (MACD) for NVDA turned negative on October 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 32 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.

NVDA moved below its 50-day moving average on October 14, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NVDA crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVDA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

The Aroon Indicator for NVDA entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 13 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 17 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. NVDA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: NVDA's P/B Ratio (19.682) is very high in comparison to the industry average of (5.443). P/E Ratio (23.477) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.478) is also within normal values, averaging (3.803). Dividend Yield (0.005) settles around the average of (0.014) among similar stocks. P/S Ratio (17.212) is also within normal values, averaging (46.468).

The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

FUNDAMENTALS RATINGS
NVDA: Fundamental Ratings
NVDA
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
17
SMR RATING
1..100
13
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ETJNVDA
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
76%
Bearish Trend 2 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement

ETJ and

Correlation & Price change

A.I.dvisor tells us that ETJ and AAPL have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ETJ and AAPL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETJ
1D Price
Change %
ETJ100%
-1.77%
AAPL - ETJ
12%
Poorly correlated
-0.62%
META - ETJ
10%
Poorly correlated
+0.00%
NVDA - ETJ
7%
Poorly correlated
-5.53%
LLY - ETJ
6%
Poorly correlated
+1.44%
MSFT - ETJ
5%
Poorly correlated
-2.20%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNWV1.880.03
+1.62%
Sanuwave Health Inc
SENEB168.050.61
+0.36%
Seneca Foods Corp
OPBK14.87-0.06
-0.40%
OP Bancorp
DNTH88.81-1.19
-1.32%
Dianthus Therapeutics
IDXX696.64-10.01
-1.42%
IDEXX Laboratories